Salem Partners
Overview
Salem Partners is a Los Angeles-based investment bank and wealth management firm founded in 1997 that provides M&A advisory, capital raising, and makes direct principal investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OncoNano Medicine | Jun 2025 | Series B Extension | Co-investor |
| GenrAb, Inc. | Apr 2025 | Seed | Co-investor |
| AsclepiX Therapeutics | Nov 2018 | Convertible Debt | Co-investor |
| Femasys Inc. | Jan 2017 | Series C Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Salem Partners based?
Salem Partners is headquartered in Los Angeles, California, United States.
When was Salem Partners founded?
Salem Partners was founded in 1997.
How many portfolio companies does Salem Partners have?
Salem Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in Salem Partners's portfolio?
Portfolio companies visible on Caplight include OncoNano Medicine, GenrAb, Inc., AsclepiX Therapeutics, Femasys Inc..
What was Salem Partners's most recent investment shown here?
Salem Partners's most recent investment in this portfolio sample was in OncoNano Medicine in 2025.
What sectors does Salem Partners focus on?
Salem Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Salem Partners focus on?
Salem Partners typically invests at the Mid stage.
What is Salem Partners's AUM?
Salem Partners's assets under management are estimated between $1.0B and $10.0B.